106462-85-5 Usage
Chemical structure
A derivative of isoquinoline with a chlorine atom and a methoxy group attached to the molecule.
Isoquinoline derivative
A type of compound derived from the isoquinoline core structure.
Chlorine atom
The presence of a chlorine atom in the molecule contributes to its chemical reactivity and properties.
Methoxy group
A functional group consisting of an oxygen atom bonded to a methyl group (-OCH3), which is attached to the isoquinoline core.
Pharmaceutical synthesis
Used as an intermediate in the synthesis of various pharmaceuticals.
Agrochemical synthesis
Also used as an intermediate in the synthesis of agrochemicals.
Therapeutic applications
Studied for its potential use in the treatment of neurodegenerative diseases and cancer.
Versatile building block
Recognized for its diverse synthetic applications in medicinal and organic chemistry.
Research interest
Of interest to chemists and researchers due to its potential in developing new drugs and chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 106462-85-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,4,6 and 2 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 106462-85:
(8*1)+(7*0)+(6*6)+(5*4)+(4*6)+(3*2)+(2*8)+(1*5)=115
115 % 10 = 5
So 106462-85-5 is a valid CAS Registry Number.
106462-85-5Relevant academic research and scientific papers
Hepatitis C virus inhibitors
-
Page/Page column 58, (2017/01/23)
Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Hepatitis C Virus Inhibitors
-
Page/Page column 136, (2008/12/05)
Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 89-90, (2010/02/11)
Hepatitis C virus inhibitors are disclosed having the general formula (I) wherein A, R2, R3, R', B and Y are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
HEPATITIS C VIRUS INHIBITORS
-
Page 332-333, (2008/06/13)
Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.
